Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies.

Abstract	Controversy surrounds the relations among infertility, fertility drug use, and the risk of ovarian cancer. The authors pooled interview data on infertility and fertility drug use from eight case-control studies conducted between 1989 and 1999 in the United States, Denmark, Canada, and Australia. Odds ratios and 95% confidence intervals were calculated, adjusting for age, race, family history of ovarian cancer, duration of oral contraception use, tubal ligation, gravidity, education, and site. Included in the analysis were 5,207 cases and 7,705 controls. Among nulligravid women, attempts for more than 5 years to become pregnant compared with attempts for less than 1 year increased the risk of ovarian cancer 2.67-fold (95% confidence interval (CI): 1.91, 3.74). Among nulliparous, subfertile women, neither any fertility drug use (odds ratio (OR) = 1.60, 95% CI: 0.90, 2.87) nor more than 12 months of use (OR = 1.54, 95% CI: 0.45, 5.27) was associated with ovarian cancer. Fertility drug use in nulligravid women was associated with borderline serous tumors (OR = 2.43, 95% CI: 1.01, 5.88) but not with any invasive histologic subtypes. Endometriosis (OR = 1.73, 95% CI: 1.10, 2.71) and unknown cause of infertility (OR = 1.19, 95% CI: 1.00, 1.40) increased cancer risk. These data suggest a role for specific biologic causes of infertility, but not for fertility drugs in overall risk for ovarian cancer.
Authors	Roberta B Ness, Daniel W Cramer, Marc T Goodman, Susanne Krûger Kjaer, Kathy Mallin, Berit Jul Mosgaard, David M Purdie, Harvey A Risch, Ronald Vergona, Anna H Wu
Journal	American journal of epidemiology (Am J Epidemiol) Vol. 155 Issue 3 Pg. 217-24 (Feb 01 2002) ISSN: 0002-9262 [Print] United States
PMID	11821246 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References	Fertility Agents, Female
Topics	Case-Control Studies Female Fertility Agents, Female (adverse effects) Humans Infertility, Female (classification, complications, epidemiology) Logistic Models Ovarian Neoplasms (chemically induced, epidemiology) Parity Pregnancy Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!